The Nutshell

» cancer and ecology

Daily News Roundup

Most Recent

image: Direct-to-Consumer Liquid Biopsy

Direct-to-Consumer Liquid Biopsy

By | September 13, 2015

Some doctors advise shoppers to be skeptical of a newly marketed cancer diagnostic.

0 Comments

image: Influential Cancer Biologist Dies

Influential Cancer Biologist Dies

By | August 24, 2015

Chris Marshall, who pieced together a critical signaling pathway involved in cancer, has passed away at age 66.

0 Comments

image: Esteemed Cancer Surgeon Dies

Esteemed Cancer Surgeon Dies

By | August 12, 2015

Carolyn Kaelin, a breast cancer surgeon, survivor, and advocate has passed away at age 54.

0 Comments

image: Butterflies in Peril

Butterflies in Peril

By | August 12, 2015

Several recent studies point to serious—and mysterious—declines in butterfly numbers across the globe.

5 Comments

image: Resveratrol’s Low-Dose Anticancer Effect

Resveratrol’s Low-Dose Anticancer Effect

By | July 31, 2015

The antioxidant found in red wine and some berries shows that small doses have more potent antitumor effects than large doses in a mouse model.

0 Comments

image: Biotech Buys Autoimmune Firm for $7B

Biotech Buys Autoimmune Firm for $7B

By | July 16, 2015

Celgene has purchased Receptos, developer of an experimental multiple sclerosis drug.

0 Comments

image: The Death Toll Tied to Sweet Drinks

The Death Toll Tied to Sweet Drinks

By | July 1, 2015

Annually, about 184,000 deaths annually are linked to drinking sugary beverages, according to a new study.

7 Comments

image: Ravenous Invasive Worm Now in U.S.

Ravenous Invasive Worm Now in U.S.

By | June 25, 2015

Researchers have found the New Guinea flatworm, one of the world’s most invasive species, in Florida, putting native ecosystems at serious risk.

0 Comments

image: More Lab-Made Nucleotides

More Lab-Made Nucleotides

By | June 8, 2015

Artificial bases that act like the real deal can be designed to bind specifically to tumor cells.

0 Comments

image: NCI Gets Personal

NCI Gets Personal

By | June 2, 2015

The National Cancer Institute is launching a Phase 2 trial matching patients with specific mutations to drugs tailored to those genetic changes.

0 Comments

Popular Now

  1. Exercise Boosts Telomere Transcription
  2. Classic Example of Symbiosis Revised
  3. The Genetic Components of Rare Diseases
  4. Orangutan Imitates Human Speech
RayBiotech